A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund
Regular
Direct
3 Year Absolute Returns
98.10% ↑
NAV (₹) on 18 Jun 2026
41.62
1 Day NAV Change
0.63%
Risk Level
Very High Risk
Rating
-
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund is a Equity mutual fund categorized under Sector, offered by ICICI Prudential Asset Management Co. Ltd.. Launched on 25 Jun 2018, ... Read more
NAV History
Fund Details
Min. SIP Amount
₹100
Inception Date
25 Jun 2018
Min. Lumpsum Amount
₹ 5,000
Fund Age
7 Yrs
AUM
₹ 6,453.52 Cr.
Benchmark
BSE Healthcare Total Return
Expense Ratio
1.81%
Scheme Type
Open Ended
Exit Load
1%
Returns Calculator
Investment amount per month
₹1,000
Over the past
Would have become
On total investment of
*Calculation based on past performance of this fund.
Asset Allocation
AUM
₹ 6,453.52 Cr
Equity
489.16%
Debt
0.06%
Money Market & Cash
15.32%
Other Assets & Liabilities
1.05%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 86.31% |
| Hospitals & Medical Services | 9.13% |
| Treps/Reverse Repo | 5.18% |
| Insurance Distributor | 1.38% |
| Chemicals - Organic - Others | 1.19% |
| Chemicals - Speciality | 1.02% |
| Medical Equipment & Accessories | 0.80% |
| Cash | 0.01% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 12.09% | ₹ 780.51 | Pharmaceuticals |
| Dr. Reddy's Laboratories Ltd. | 7.70% | ₹ 496.84 | Pharmaceuticals |
| Cipla Ltd. | 7.45% | ₹ 480.68 | Pharmaceuticals |
| Mankind Pharma Ltd. | 7.03% | ₹ 453.64 | Pharmaceuticals |
| Divi's Laboratories Ltd. | 6.06% | ₹ 391.33 | Pharmaceuticals |
| TREPS | 5.18% | ₹ 334.20 | Others |
| Biocon Ltd. | 4.71% | ₹ 304.27 | Pharmaceuticals |
| Cohance Lifesciences Ltd. | 4.37% | ₹ 282.16 | Pharmaceuticals |
| Alkem Laboratories Ltd. | 4.08% | ₹ 263.44 | Pharmaceuticals |
| Medplus Health Services Ltd | 3.86% | ₹ 249.05 | Pharmaceuticals |
| MAX Healthcare Institute Ltd | 3.36% | ₹ 217.15 | Hospitals & Medical Services |
| Lupin Ltd. | 3.06% | ₹ 197.28 | Pharmaceuticals |
| Syngene International Ltd. | 2.99% | ₹ 192.73 | Pharmaceuticals |
| Thyrocare Technologies Ltd. | 2.40% | ₹ 154.56 | Hospitals & Medical Services |
| Abbott India Ltd. | 2.14% | ₹ 137.96 | Pharmaceuticals |
| Akums Drugs and Pharmaceuticals Ltd. | 2.01% | ₹ 129.40 | Pharmaceuticals |
| Pfizer Ltd. | 1.98% | ₹ 127.57 | Pharmaceuticals |
| J.B.Chemicals & Pharmaceuticals Ltd. | 1.94% | ₹ 125.43 | Pharmaceuticals |
| Aurobindo Pharma Ltd. | 1.92% | ₹ 124.15 | Pharmaceuticals |
| Alivus Life Sciences Ltd. | 1.77% | ₹ 114.04 | Pharmaceuticals |
| Alembic Pharmaceuticals Ltd. | 1.76% | ₹ 113.46 | Pharmaceuticals |
| Entero Healthcare Solutions | 1.74% | ₹ 112.46 | Pharmaceuticals |
| Metropolis Healthcare Ltd. | 1.54% | ₹ 99.09 | Hospitals & Medical Services |
| Rainbow Childrens Medicare Ltd | 1.44% | ₹ 93 | Hospitals & Medical Services |
| Blue Jet Healthcare Ltd. | 1.40% | ₹ 90.24 | Pharmaceuticals |
| Medi Assist Healthcare Services Ltd | 1.38% | ₹ 88.75 | Insurance Distributor |
| Hikal Ltd. | 1.21% | ₹ 78.11 | Pharmaceuticals |
| Fine Organic Industries Ltd. | 1.19% | ₹ 76.86 | Chemicals - Organic - Others |
| Aarti Drugs Ltd. | 1.10% | ₹ 70.96 | Pharmaceuticals |
| Sanofi Consumer Healthcare India Ltd | 1.02% | ₹ 66.06 | Chemicals - Speciality |
| Windlas Biotech Ltd. | 0.96% | ₹ 61.69 | Pharmaceuticals |
| Laxmi Dental Ltd. | 0.80% | ₹ 51.34 | Medical Equipment & Accessories |
| Astrazeneca Pharma India Ltd. | 0.78% | ₹ 50.31 | Pharmaceuticals |
| FDC Ltd. | 0.77% | ₹ 49.61 | Pharmaceuticals |
| Shilpa Medicare Ltd. | 0.71% | ₹ 46.03 | Pharmaceuticals |
| Indoco Remedies Ltd. | 0.47% | ₹ 30.35 | Pharmaceuticals |
| Jupiter Life Line Hospitals Ltd | 0.39% | ₹ 25.36 | Hospitals & Medical Services |
| Anthem Biosciences Ltd | 0.25% | ₹ 15.95 | Pharmaceuticals |
| Cash Margin - Derivatives | 0.01% | ₹ 0.41 | Others |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 1.46% | 7.55% | 13.55% | 25.59% |
| Category returns | 1.67% | 5.74% | 7.21% | 22.82% |
Fund Objective
To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied ... Read more
AMC Details
Name
ICICI Prudential Asset Management Co. Ltd.
Date of Incorporation
12 Oct 1993
CEO
Mr. Nimesh Shah
CIO
Mr. S Naren
Type
Pvt.Sector-Joint Venture (Indian)
Address
One BKC, A-Wing,
13th Floor,
Bandra Kurla Complex, Mumbai, Maharashtra, India - 400051
Website
http://www.icicipruamc.com
Email
Top Funds from Equity - Sectoral/Thematic
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹39.90 | 202.92% | 342.40% | 0.00% | ₹1,256 | 0.85% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹39.90 | 202.92% | 342.40% | 0.00% | ₹1,256 | 0.85% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹39.90 | 202.92% | 342.40% | 0.00% | ₹1,256 | 0.85% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹37.37 | 198.79% | 324.40% | 0.00% | ₹1,256 | 2.15% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹37.37 | 198.79% | 324.40% | 0.00% | ₹1,256 | 2.15% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹37.37 | 198.79% | 324.40% | 0.00% | ₹1,256 | 2.15% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.24 | 16.07% | 199.31% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.24 | 16.07% | 199.31% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.24 | 16.07% | 199.31% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29.22 | 14.91% | 189.42% | 0.00% | ₹9,724 | 1.75% |
Very High
|
Top Funds from ICICI Prudential Asset Management Co. Ltd.
FAQs
What is the current NAV of ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Regular Growth?
The current Net Asset Value (NAV) of ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Regular Growth is ₹41.62 as of 18 Jun 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Regular Growth?
The Assets Under Management (AUM) of ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Regular Growth is ₹6,453.52 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Regular Growth?
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Regular Growth has delivered returns of 7.55% (1 Year), 25.59% (3 Year), 15.73% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Regular Growth?
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Regular Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Regular Growth?
The minimum lumpsum investment required for ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Regular Growth is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹100, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
-
గ్రీన్ ఎనర్జీలో పెట్టుబడికి ఇదే చివరి అవకాశం: మోతీలాల్ ఓస్వాల్ NFO వివరాలు ఇవే! -
AISలో మ్యూచువల్ ఫండ్ వివరాలు మారాయి: ITR ఫైల్ చేసే ముందు ఈ తప్పులు చేయకండి! -
సెబీ కీలక నిర్ణయం: మ్యూచువల్ ఫండ్ ఇన్వెస్టర్ల పెట్టుబడికి ఇక తిరుగులేదా? -
బిగ్ ఫండ్స్ సీక్రెట్ లీక్: దేశంలోని 3 అతిపెద్ద మ్యూచువల్ ఫండ్స్ నమ్ముకున్న ఆ 5 షేర్లు ఇవే! -
స్మాల్క్యాప్ ఇన్వెస్టర్లకు అలర్ట్: ఐసీఐసీఐ ఈటీఎఫ్ ఎన్ఎఫ్ఓ నేడే ముగింపు - మీరు సిద్ధమేనా? -
సింగపూర్ NRI సంచలనం! రూ. కోటిన్నర లాభం వచ్చినా జీరో టాక్స్! కొత్త టాక్స్ రూల్స్లో ఉన్న ట్విస్ట్ ఇదే! -
యాక్సిస్ మ్యూచువల్ ఫండ్ ఇన్వెస్టర్లకు శుభవార్త: ఇకపై ఎగ్జిట్ లోడ్ ఉండదు, పూర్తి వివరాలు ఇవే! -
మార్కెట్ ఒడిదుడుకులు.. అయినా రికార్డు స్థాయిలో SIP పెట్టుబడులు: ఇన్వెస్టర్ల తెలివైన నిర్ణయం! -
ఈక్విటీ ఇన్ ఫ్లోస్ తగ్గుముఖం.. అయినా తగ్గని SIP జోరు: ఇన్వెస్టర్ల తెలివైన నిర్ణయం ఇదే! -
ఐసీఐసీఐ ప్రుడెన్షియల్ సరికొత్త 'NFO'.. ఒకే పెట్టుబడితో 250 స్మాల్క్యాప్ కంపెనీల్లో భాగస్వామ్యం!
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+